High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$199K
$199,403
Total Sells (Filtered)
$5.5M
$5,511,916
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| EWTX |
Edgewise Therapeutics, Inc.
|
Director
Other
|
2026-01-21 | $170,264x5 | M | Form 4 |
|
EWTX
S
Edgewise Therapeutics, Inc.
Edris Badreddin
• Director
10b5-1 Sell
2026-01-21
$3,399,466Largex5
|
||||||
| EWTX |
Edgewise Therapeutics, Inc.
|
Director
10b5-1 Sell
|
2026-01-21 | $3,399,466Largex5 | S | Form 4 |
|
EWTX
M
Edgewise Therapeutics, Inc.
Russell Alan J
• Officer • Chief Scientific Officer
Other
2025-11-12
$18,000
|
||||||
| EWTX |
Edgewise Therapeutics, Inc.
|
Officer • Chief Scientific Officer
Other
|
2025-11-12 | $18,000 | M | Form 4 |
|
EWTX
S
Edgewise Therapeutics, Inc.
Russell Alan J
• Officer • Chief Scientific Officer
Discretionary SellΔOwn -81.0%
2025-11-12
$2,112,450Large
|
||||||
| EWTX |
Edgewise Therapeutics, Inc.
|
Officer • Chief Scientific Officer
Discretionary SellΔOwn -81.0%
|
2025-11-12 | $2,112,450Large | S | Form 4 |
|
EWTX
P
Edgewise Therapeutics, Inc.
Fox Jonathan C
• Director
Discretionary BuyΔOwn +82.3%
2025-11-11
$199,403
|
||||||
| EWTX |
Edgewise Therapeutics, Inc.
|
Director
Discretionary BuyΔOwn +82.3%
|
2025-11-11 | $199,403 | P | Form 4 |